1 Magnificent Growth Stock Down 55% to Buy Right Now, According to Wall Street

Zscaler reported record fiscal 2026 revenue of $3.35 billion, up 25% year over year and above its latest $3.33 billion forecast, while its "Zero Trust Everywhere" customer count rose 171% to 950. Fiscal 2027 guidance implies a slower roughly 17% revenue-growth rate, reflecting expected near-term sales disruption after the departure of two senior sales employees. Wall Street remains bullish, with 39 of 49 tracked analysts rated buy/overweight and a $207.40 average target implying 25% upside; Zscaler trades at 7.9x sales versus 22.1x for Palo Alto Networks and 39.6x for CrowdStrike.

Analysis

ZS’s discount should not be read as a simple multiple-arbitrage opportunity. PANW and CRWD command premiums because investors assign them broader platform consolidation and/or faster durable growth; ZS must demonstrate that its AI-agent controls convert into incremental platform spend rather than a feature bundled into existing secure-access budgets. The near-term setup is therefore earnings-execution driven: any evidence that sales-force disruption is contained and billings/RPO stabilize above the guided growth profile could produce a sharp rerating, while a miss would reinforce concerns that the category is commoditizing.

The more attractive second-order expression is a potential share shift away from legacy network-security architectures. Agentic deployments expand the number of machine identities and application-to-application connections, increasing the value of policy enforcement at the access layer; that favors ZS if customers standardize on its architecture. But hyperscalers and PANW can package adjacent controls into larger enterprise agreements, making win rates and net retention—not AI product announcements—the key validation metrics over the next 1-3 quarters.

Consensus appears overly focused on the historical valuation discount and analyst targets. A return to prior peak sales multiples is not a base case under a lower-growth, more competitive software regime; upside should be underwritten from a modest growth reacceleration and improving free-cash-flow conversion. Conversely, ZS’s lack of bearish ratings raises crowded-long risk if the next results expose prolonged sales-execution issues.

Key Decisions for Investors

• Initiate a modest long ZS / short PANW pair over the next 1-3 months only if ZS trades at a materially wider EV/sales discount than its recent range; thesis is sales-execution normalization and zero-trust share gains, not full multiple convergence. Target 15-25% relative upside; exit if ZS billings or RPO growth decelerates for two consecutive reports.
• Ahead of the next ZS earnings, use a defined-risk call spread rather than outright stock if implied volatility is below its post-earnings move history: buy 3-6 month near-ATM calls and sell calls 15-20% higher. This captures a guidance-reset reversal while limiting exposure to a sales-disruption miss.
• Do not chase AI-security headlines across ZS, PANW, or CRWD. Set an alert for disclosed AI-security attach rates, large-platform deal additions, and net-retention trends; absent measurable monetization, treat the AI narrative as valuation support rather than an earnings catalyst.
• For a bearish hedge, reduce ZS exposure or add puts if management cuts the full-year billings outlook, enterprise deal cycles lengthen, or operating-margin expansion stalls. Those outcomes would undermine the premise that current growth is a temporary execution trough and could sustain the valuation discount for 6-12 months.